Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy

Mov Disord. 2022 May;37(5):1108-1109. doi: 10.1002/mds.29011.

Morten Andreas Horn¹, Anders Eivind Myhre², Trine Prescott³, Jan Aasly^{4

5}, Christina Heidemann Sundal^{6

7}, Tobias Gedde-Dahl^{2

8}

¹ Department of Neurology, Oslo University Hospital, Oslo, Norway.
² Department of Hematology, Oslo University Hospital, Oslo, Norway.
³ Section of Medical Genetics, Department of Laboratory Medicine, Telemark Hospital Trust, Skien, Norway.
⁴ Department of Neurology, St. Olavs Hospital, Trondheim, Norway.
⁵ Department of Neuroscience, NTNU, Trondheim, Norway.
⁶ Department of Neurology, NeuroClinic, Lillestrøm, Norway.
⁷ Department of Neurology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
⁸ Division of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

No abstract available

Publication types